Mass spectrometry and molecular modeling studies on the inclusion complexes between alendronate and β-cyclodextrin
Open Access
- 17 April 2013
- journal article
- research article
- Published by Springer Nature in Journal of Inclusion Phenomena and Macrocyclic Chemistry
- Vol. 78 (1-4) , 437-443
Abstract
Complexation of alendronate sodium (AlnNa) with β-cyclodextrin (β-CD) was studied by means of ESI-mass spectrometry. The experimental results show that stable 1:1 inclusion complexes between selected bisphosphonates and β-CD were formed. In addition, complexes with different stoichiometry were observed. DFT/B3LYP calculations were performed to elucidate the different inclusion behavior between alendronate and β-CD. Molecular modeling showed that the inclusion complex of Aln-β-CD where the two phosphonate groups bound to the central carbon atom of bisphosphonate were inserted into the cavity of β-CD from its “top” side was thermodynamically more favorable than when they were inserted from its “bottom” side; the complexation energy was −74.05 versus −60.85 kcal/mol. The calculations indicated that the formation of conventional hydrogen bonds was the main factor for non-covalent β-CD:Aln complex formation and stabilization in the gas phase.Keywords
This publication has 23 references indexed in Scilit:
- Cyclodextrins and their pharmaceutical applicationsInternational Journal of Pharmaceutics, 2007
- Elimination of bitter, disgusting tastes of drugs and foods by cyclodextrinsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2005
- Cyclodextrin-based pharmaceutics: past, present and futureNature Reviews Drug Discovery, 2004
- NMR studies of the inclusion complex between β-cyclodextrin and paroxetineEuropean Journal of Pharmaceutical Sciences, 2004
- Cyclodextrins and their uses: a reviewProcess Biochemistry, 2004
- Coordination features of difunctionalized β-cyclodextrins with carnosine: ESI-MS and spectroscopic investigations on 6A,6D-di-(β-alanyl-l-histidine)-6A,6D-dideoxy-β-cyclodextrin and 6A,6C-di-(β-alanyl-l-histidine)-6A,6C-dideoxy-β-cyclodextrin and their copper(II) complexesJournal of Inorganic Biochemistry, 2004
- Driving Forces for the Inclusion of the Drug Tolmetin by β-Cyclodextrin in Aqueous Medium. Conductometric and Molecular Modeling StudiesLangmuir, 1999
- Pharmacokinetics of AlendronateClinical Pharmacokinetics, 1999
- Esophagitis Associated with the Use of AlendronateNew England Journal of Medicine, 1996
- Pharmaceutical Applications of Cyclodextrins. 1. Drug Solubilization and StabilizationJournal of Pharmaceutical Sciences, 1996